| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1078 | 2009 |
| Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging … A Grieco, M Pompili, G Caminiti, L Miele, M Covino, B Alfei, GL Rapaccini, ... Gut 54 (3), 411-418, 2005 | 299 | 2005 |
| Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert … P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ... Digestive and Liver Disease 42 (4), 272-282, 2010 | 285 | 2010 |
| Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 272 | 2015 |
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota ML Balmer, E Slack, A De Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ... Science translational medicine 6 (237), 237ra66-237ra66, 2014 | 242 | 2014 |
| Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ... Free Radical Biology and Medicine 52 (9), 1658-1665, 2012 | 197 | 2012 |
| Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis L Miele, S Vallone, C Cefalo, G La Torre, C Di Stasi, FM Vecchio, ... Journal of hepatology 51 (4), 778-786, 2009 | 190 | 2009 |
| The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008 | 183 | 2008 |
| A 360-degree overview of paediatric NAFLD: recent insights V Nobili, G Svegliati-Baroni, A Alisi, L Miele, L Valenti, P Vajro Journal of hepatology 58 (6), 1218-1229, 2013 | 156 | 2013 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 150 | 2017 |
| Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome G Targher, M Chonchol, L Miele, G Zoppini, I Pichiri, M Muggeo Seminars in thrombosis and hemostasis 35 (03), 277-287, 2009 | 143 | 2009 |
| High efficacy of 1‐week doxycycline‐and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection G Cammarota, A Martino, G Pirozzi, R Cianci, G Branca, EC Nista, ... Alimentary pharmacology & therapeutics 19 (7), 789-795, 2004 | 139 | 2004 |
| Breath testing for human liver function assessment A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, ... Alimentary pharmacology & therapeutics 16 (12), 1977-1996, 2002 | 130 | 2002 |
| Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test L Miele, A Grieco, A Armuzzi, M Candelli, A Forgione, A Gasbarrini, ... The American journal of gastroenterology 98 (10), 2335, 2003 | 111 | 2003 |
| Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ... Digestive and Liver Disease 46 (6), 556-560, 2014 | 108 | 2014 |
| Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity AL Fracanzani, L Valenti, E Bugianesi, E Vanni, A Grieco, L Miele, ... Journal of hepatology 54 (6), 1244-1249, 2011 | 107 | 2011 |
| Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review M Pompili, M Biolato, L Miele, A Grieco World Journal of Gastroenterology: WJG 19 (44), 7867, 2013 | 101 | 2013 |
| Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta‐analysis AE Pontiroli, L Miele, A Morabito Diabetes, Obesity and Metabolism 13 (11), 1008-1019, 2011 | 100 | 2011 |
| Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk L Miele, V Giorgio, MA Alberelli, E De Candia, A Gasbarrini, A Grieco Current cardiology reports 17 (12), 120, 2015 | 94 | 2015 |
| Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target L Miele, G Marrone, C Lauritano, C Cefalo, A Gasbarrini, C Day, A Grieco Current Pharmaceutical Design 19 (29), 5314-5324, 2013 | 93 | 2013 |
Antonio GriecoProfessore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, RomaEmail verificata su rm.unicatt.it
